NYSE:EW

Edwards Lifesciences Stock News

etoro logo Buy EW
*Your capital is at risk
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Within the TAVR arm, Edwards Lifesciences (EW) is likely to have witnessed continued growth in procedures across the United States and worldwide.
Edwards Lifesciences (EW) expects full-year 2022 underlying sales growth in the mid-single-digit range on the back of strength in demand for products used in more intense surgeries.

These Are the Top 10 Holdings of David Rolfe

08:02pm, Tuesday, 04'th Oct 2022
David A. Rolfe is the chief investment officer at Wedgewood Partners and has been managing Wedgewood's portfolio for 18 years.

Stocks To Watch: Big Events For Tesla, Amazon And Intel

01:08am, Saturday, 24'th Sep 2022 Seeking Alpha
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
Within the last quarter, Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 3 1 0 0 Las
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61

Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve

03:26pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.

Edward Lifesciences (EW) Gains From New Products Amid Cost Woe

03:58pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.

OCPNY or EW: Which Is the Better Value Stock Right Now?

03:40pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
OCPNY vs. EW: Which Stock Is the Better Value Option?
OCPNY vs. EW: Which Stock Is the Better Value Option?
Investors do not seem convinced that Edwards Lifesciences Corp. ( EW , Financial) is well equipped to handle a downturn in the medical device industry. Despite what one analyst thinks, the Irving, Cal

Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision

04:44pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.
Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE